SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 862.67 |
| Enterprise Value ($M) | 679.08 |
| Book Value ($M) | 438.44 |
| Book Value / Share | 10.44 |
| Price / Book | 1.97 |
| NCAV ($M) | 189.68 |
| NCAV / Share | 4.52 |
| Price / NCAV | 4.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.10 |
| Return on Assets (ROA) | -0.08 |
| Return on Equity (ROE) | -0.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.04 |
| Current Ratio | 3.30 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 331.80 |
| Assets | 580.55 |
| Liabilities | 142.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 423.24 |
| Operating Income | -45.62 |
| Net Income | -43.19 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Increase Decrease Due To Revision In Calculated Weighted Average Shares | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 25.69 |
| Cash from Investing | 37.67 |
| Cash from Financing | 12.27 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Tang Capital Management Llc | 5.20 | ||
| 13G/A | Fairmount Funds Management LLC | 0.00 | -100.00 | |
| 13G/A | Hillhouse Capital Advisors, Ltd. | 3.90 | -59.20 | |
| 13G/A | Rubric Capital Management LP | 5.96 | -16.80 | |
| 13G | BlackRock, Inc. | 9.40 | 0.00 | |
| 13D/A | Baker Bros. Advisors Lp | 7.70 | 8.54 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 94,096 | 429,941 | 21.89 | |
| 109,585 | 608,176 | 18.02 | |
| 83,796 | 338,305 | 24.77 | |
| 129,448 | 487,814 | 26.54 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IRWD – Ironwood Pharmaceuticals, Inc. | JAZZ – Jazz Pharmaceuticals plc |
| KMDA – Kamada Ltd. | KPTI – Karyopharm Therapeutics Inc. |
| KRON – Kronos Bio, Inc. |
Financial data and stock pages provided by
Fintel.io